On the Record · GSK
GSK competitors, on the record
The companies whose own annual reports name GSK as a competitor, each with the sentence it appears in and the filing it came from.
Who GSK names
GSK’s annual reports for 2023 to 2025 describe its competition by kind of business and do not name competing companies.
Who names GSK
Companies whose own annual reports name GSK as a competitor.
Word for word“GSK JEMPERLI U.S., Europe, Asia Pacific & China” 10-K for 2025
Word for word“Our direct competitors in the PRC and global markets by product category include: • Hepatitis A: AIM Vaccine, IMBCAMS, Pukang Biological, CNBG (Domestic); GSK, Merck (International).” 20-F for 2025
Read from GSK’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-06. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.